Patti, Giuseppe Rocco Salvatore
 Distribuzione geografica
Continente #
EU - Europa 6.053
NA - Nord America 5.416
AS - Asia 4.776
SA - Sud America 1.342
AF - Africa 309
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.912
Nazione #
US - Stati Uniti d'America 5.210
IE - Irlanda 2.316
SG - Singapore 1.627
HK - Hong Kong 1.219
BR - Brasile 1.066
IT - Italia 808
UA - Ucraina 702
CN - Cina 689
RU - Federazione Russa 630
VN - Vietnam 561
SE - Svezia 481
DE - Germania 457
BJ - Benin 171
GB - Regno Unito 137
KR - Corea 136
IN - India 122
CA - Canada 114
AR - Argentina 103
FR - Francia 86
ID - Indonesia 78
CZ - Repubblica Ceca 74
PL - Polonia 64
ZA - Sudafrica 64
MX - Messico 62
AT - Austria 58
BD - Bangladesh 55
NL - Olanda 54
JP - Giappone 52
FI - Finlandia 51
EC - Ecuador 47
IR - Iran 38
IQ - Iraq 36
TR - Turchia 32
CO - Colombia 31
ES - Italia 29
BE - Belgio 28
LT - Lituania 27
PE - Perù 23
PK - Pakistan 22
CL - Cile 21
PY - Paraguay 19
MA - Marocco 17
VE - Venezuela 16
SA - Arabia Saudita 13
UY - Uruguay 13
KE - Kenya 12
MY - Malesia 12
AU - Australia 11
CH - Svizzera 11
EG - Egitto 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 9
IL - Israele 8
PH - Filippine 8
TN - Tunisia 8
AL - Albania 7
RS - Serbia 7
TH - Thailandia 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
ET - Etiopia 6
JO - Giordania 6
KZ - Kazakistan 5
NG - Nigeria 5
PA - Panama 5
UZ - Uzbekistan 5
GR - Grecia 4
KW - Kuwait 4
LB - Libano 4
MO - Macao, regione amministrativa speciale della Cina 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BB - Barbados 3
BG - Bulgaria 3
JM - Giamaica 3
MT - Malta 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EU - Europa 2
HN - Honduras 2
LI - Liechtenstein 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AM - Armenia 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
Totale 17.899
Città #
Dublin 2.272
Jacksonville 1.250
Hong Kong 1.202
Singapore 557
Ashburn 442
Beijing 440
Lawrence 281
Princeton 281
Wilmington 279
Los Angeles 237
Ho Chi Minh City 211
Buffalo 173
Cotonou 171
Moscow 168
Hanoi 130
Seoul 128
São Paulo 112
Munich 105
Novara 103
Milan 85
New York 85
Redondo Beach 85
Chandler 82
Brno 72
San Mateo 62
Ann Arbor 55
Warsaw 54
Dallas 49
Nuremberg 49
Bremen 48
Johannesburg 43
Houston 41
Tianjin 41
London 40
Rome 40
Santa Clara 40
Chennai 38
Piemonte 38
Tokyo 37
Turin 37
Vercelli 34
Denver 33
Helsinki 33
Frankfurt am Main 32
Montreal 32
Mülheim 32
Toronto 32
Brooklyn 31
Falkenstein 30
Chicago 29
Atlanta 28
Brussels 28
Poplar 28
Mexico City 27
Norwalk 27
Vienna 27
Rio de Janeiro 26
Orem 25
Seattle 25
Assago 24
Phoenix 24
Boardman 22
Haiphong 22
Jakarta 22
Stockholm 22
Da Nang 21
Fairfield 21
Guayaquil 21
Boston 20
Torino 20
West Jordan 20
Amsterdam 19
Porto Alegre 19
Curitiba 18
New Delhi 18
Ankara 17
Brasília 17
Turku 17
Manchester 16
Menlo Park 15
San Francisco 15
Andover 14
Belo Horizonte 14
Elk Grove Village 14
Ottawa 14
Biên Hòa 13
Lima 13
Woodbridge 13
Paris 12
Quito 12
Buenos Aires 11
Campinas 11
Dhaka 11
Fortaleza 11
Hải Dương 11
Monmouth Junction 11
Nairobi 11
Ninh Bình 11
Goiânia 10
Montevideo 10
Totale 10.879
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 330
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 205
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 149
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 138
Change over time of COVID-19 hospital presentation in Northern Italy 132
Strike early–strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry 127
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 120
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 119
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 117
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 107
One-Year Follow up of Noninvasive Respiratory Support in General Wards 100
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 99
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 95
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 95
Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis 95
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 93
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 92
Dieci quesiti in tema di test da sforzo cardiopolmonare: tutto quello che il cardiologo osa e non osa chiedere 90
Metabolomics diagnosis of covid-19 from exhaled breath condensate 90
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 87
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy 86
Reduction of admissions for urgent and elective pacemaker implant during the COVID-19 outbreak in Northern Italy 86
Cardiopulmonary exercise testing is an accurate tool for the diagnosis of pulmonary arterial hypertension in scleroderma related diseases 82
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 80
Safety and Efficacy of Different Antithrombotic Strategies After Transcatheter Aortic Valve Implantation: A Network Meta-Analysis 79
A nurse-led coaching intervention with home telemonitoring for patients with heart failure: Protocol for a feasibility randomized clinical trial 76
Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning 75
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 75
Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention 74
Aggiornamenti in tema di terapia antitrombotica dopo chiusura percutanea dell’auricola sinistra 73
Causes of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: findings from the SYNCOPACED registry 73
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study * 71
Characterization of Circulating Vesicles of Complicated and Uncomplicated Systemic Sclerosis Patients and Their Role in Vascular Dysfunction 69
Clustering of blood cell count abnormalities and future risk of death 69
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 69
Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology 68
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak 68
[Zero-fluoroscopy transcatheter ablation and CRT-D implantation: new frontiers of electroanatomical mapping systems] 67
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial) 67
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles 67
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry 67
Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak 67
Intracardiac Versus Transesophageal Echocardiography for Assisting Percutaneous Left Atrial Appendage Occlusion?: “Veni, vidi, vICE”! 65
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation 65
Terapie antitrombotiche in pazienti con infezione da SARS-CoV-2: Dalle attuali evidenze alle ragionevoli raccomandazioni – Position paper del gruppo di studio aterosclerosi, trombosi e biologia vascolare 65
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 65
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment 64
Percutaneous coronary interventions and statin therapy 64
Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials 63
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin Study) 63
Risk of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: Role of correlation between symptoms and electrocardiogram findings 63
Infective endocarditis complicating COVID-19 pneumonia: a case report 63
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 62
[Proposal for a diagnostic and therapeutic care pathway of the Piedmont Region on lipid-lowering and antithrombotic treatment in patients with peripheral arterial disease] 61
Antibiotic prophylaxis and treatment of cardiovascular disease - Response 61
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications 61
A clinical-in silico study on the effectiveness of multipoint bicathodic and cathodic-anodal pacing in cardiac resynchronization therapy 61
Left bundle branch area pacing (LBBAP) Auto Threshold algorithms Evaluation for Conduction System Pacing: The LATECS pilot Trial 60
Kounis Syndrome: an underestimated emergency 60
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry 60
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials 60
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 60
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study 60
Updated antithrombotic strategies to reduce the burden of cardiovascular recurrences in patients with chronic coronary syndrome 59
Prevention of ischaemic events in subjects with polydistrict vascular disease 59
Unmasking of a significant left main stenosis in a patient with high left ventricular pressures 58
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses 58
Management of patients explanted for implantable cardioverter defibrillator infections: Bridge therapy with external temporary ICD 58
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study 58
Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization 58
Point-of-Care Assessment of Platelet Reactivity After Clopidogrel to Predict Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention 58
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 58
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry 58
Usefulness of a multiparametric evaluation including global longitudinal strain for an early diagnosis of acute myocarditis 58
Left atrial conduit flow rate at baseline and during exercise: an index of impaired relaxation in HFpEF patients 57
Transapical closure of paraprosthetic mitral leak in a patient with inferior vena cava interruption and azygos continuation 57
Speckle Tracking Echocardiography: Early Predictor of Diagnosis and Prognosis in Coronary Artery Disease 57
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 57
Atrio-ventricular block in a young patient with multisystemic c-antineutrophilic cytoplasmic antibody vasculitis with myocardial involvement: a case report 56
Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning 56
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 56
Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis 56
Percutaneous closure of a pulmonary arteriovenous malformation in young patient with cryptogenic stroke 56
New echocardiographic indices of shift to biventricular failure to optimize risk stratification of chronic heart failure 56
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 56
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry 55
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 55
Outcome Comparison of 600-and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Results From the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Randomized Study 55
Coronary sinus for cardiac resynchronization therapy: leave it alone and go for the branch! a case report 54
Impact of a personalized, strike early and strong lipid-lowering approach on low-density lipoprotein-cholesterol levels and cardiovascular outcome in patients with acute myocardial infarction 54
Research into New Molecular Mechanisms in Thrombotic Diseases Paves the Way for Innovative Therapeutic Approaches 54
Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation 54
Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention A Collaborative Patient-Level Meta-Analysis of 13 Randomized Studies 54
Long-term outcome of sirolimus-eluting vs bare-metal stent in the setting of acute myocardial infarction: 5-year results of the SESAMI trial 54
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 54
Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE) 54
Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation 53
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 53
Arrhythmic Risk Stratification and Sudden Cardiac Death Prevention in Duchenne Muscular Dystrophy: A Critical Appraisal 53
Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease 53
Totale 7.463
Categoria #
all - tutte 137.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.687


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.078 0 0 0 0 0 29 477 15 247 31 264 15
2021/20221.266 56 34 64 91 72 22 43 49 147 72 242 374
2022/20233.291 327 108 144 30 93 127 79 98 2.083 22 133 47
2023/20241.577 78 79 80 45 307 38 217 63 68 77 100 425
2024/20254.018 102 22 141 43 85 261 416 395 1.175 477 162 739
2025/20265.714 602 524 1.097 2.097 1.190 204 0 0 0 0 0 0
Totale 18.611